Clevo Co (2362)
Taiwan Stock Exchange · Taiwan · prices in TWD · close of 22 Oct 2026
Key indicators
| Last close | TWD 48.10 |
|---|---|
| 52-week range | 36.55 – 52.10 |
| Return, 1 month / 3 months | +0.4% / +11.1% |
| Return, 1 year / 3 years | +23.1% / +73.1% |
| Trend | Uptrend |
| RSI (14) | 54 |
| Volatility (1 year) | 35.6% |
| Worst drawdown (1 year) | -18.6% |
| Average daily value traded | 63.18M TWD |
| Dividend yield | 4.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Clevo Co is a Taiwanese computer maker based in Taipei that designs and builds notebook computers, including barebone laptops that other companies brand and market under their own names. It works largely as an original design manufacturer, supplying hardware to computer brands and resellers rather than selling mainly under its own label. Its products serve both consumer and business buyers of portable computers, and the company also has interests in retail and property activities in Taiwan.
On this site Clevo Co appears as a stock on the Taiwan Stock Exchange (Taiwan), code 2362, with prices in New Taiwan dollars (TWD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Clevo Co (2362) trades on the Taiwan Stock Exchange in Taiwan. It last closed at TWD 48.10 on 22 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 100 of 1,101 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 23.1% and over the last three months it rose 11.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Taiwan Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.8% | ||
| From 52-week high | -7.3% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.1% | ||
| 6-month return | 27.6% | ||
| 12-month return, skipping the last month | 22.6% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.6% | ||
| Liquidity | 62 · Fair | Moderate trading activity. | |
| Average daily value traded | 63.18M TWD | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.2% |
|---|---|
| 1 month | +0.4% |
| 3 months | +11.1% |
| 6 months | +27.6% |
| 1 year | +23.1% |
| 3 years | +73.1% |
| 5 years | +92.2% |
Signals
| 50-day / 200-day average | 47.72 / 41.53 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.01 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Jun 2026 | TWD 2.0000 |
| 24 Jun 2025 | TWD 2.5298 |
| 19 Jun 2024 | TWD 1.6000 |
| 20 Jun 2023 | TWD 1.5000 |
| 24 Jun 2022 | TWD 2.1000 |
| 20 Jul 2021 | TWD 0.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Taiwan Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.